Preceptis Medical Inc.

Preceptis Medical Inc. manufactures the Hummingbird Tympanostomy Tube System (TTS), an FDA-cleared medical device that enables in-office pediatric ear tube placement without general anesthesia. The system is designed for ENT surgeons to perform tympanostomy tube insertion in an office setting, addressing the approximately 1 million pediatric ear tube procedures performed annually in the United States. The Hummingbird procedure eliminates the need for operating room facilities, general anesthesia, pre-operative testing, and post-operative recovery restrictions. Clinical benefits include immediate return to normal activities, completion in minutes, and up to 65% cost savings compared to traditional OR-based surgical approaches. The device is particularly valuable for pediatric patients with recurrent otitis media, as it restores proper middle ear ventilation and reduces fluid buildup. Preceptis Medical markets the Hummingbird to ENT physicians and pediatric families, providing physician education resources, patient support materials, and a locator service to connect patients with trained providers. The company maintains FDA 510(k) clearance and appears to operate a network of participating ENT practices offering the procedure.